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Received 7 April 2016; revised 1 June 2016; accepted 1 June 2016AbstractObjective: To investigate immune-related genetic background in bilateral sudden sensorineural hearing loss (SSNHL).
Case report and methods: The case is a 45-year-old man presenting with a 7-year history of bilateral profound SSNHL. Blood biochemical
testing demonstrated increased levels of total cholesterol (5.88 mmol/L). Tests for hepatitis B showed a positive antibody against the hepatitis B
core antigen. Complement C3 was below the normal value, and complement C4 and IgG were in the lower range of normal values. CT images
showed a normal inner ear and vestibular aqueduct but round window membranous ossification on both sides. A total number of 232 immune-
associated genes were sequenced using the next generation sequencing technique.
Results: Mutations were detected in 5 genes, including the phosphoinositide 3-kinase catalytic subunit delta (PIK3CD), caspase recruitment
domain-containing protein 9 (CARD9), complement factor H-related (CFHR2), immunoglobulin lambda-like polypeptide 1 Protein (IGLL1),
and transmembrane channel-like gene family 8 (TMC8). In the PIK3CD gene, a C896T substitute in exon 7 was detected. This mutation causes
primary immunodeficiency and is an autosomal dominant disease.
Conclusion: The PIK3CD C896T mutation responsible for primary immunodeficiency may contribute to the onset of bilateral SSNHL with
subsequent rapid progression.
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Sudden sensorineural hearing loss (SSNHL) has an acute
onset and severely affects patient quality of life by limiting
their ability to communicate with others (Stachler et al., 2012).
The etiology of SSNHL is unclear, and viral infection, im-
mune dysregulation and metabolic disorders may be involved
in the development of the disease (Aimoni et al., 2010; Cadoni
et al., 2002; Liao et al., 1992; Mayot et al., 1993; Passamontigy Head and Neck Surgery. Production and hosting by Elsevier (Singapore)
eativecommons.org/licenses/by-nc-nd/4.0/).
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treatment for SSNHL remains controversial. In stark contrast
to unilateral SSNHL, bilateral SSNHL is less common, but has
specific distinguishing characteristics and is most often asso-
ciated with toxic, autoimmune, neoplastic and vascular con-
ditions. Patients with bilateral SSNHL have more severe (often
profound) hearing loss, poorer recovery and a 35% mortality
rate (Oh et al., 2007; Sara et al., 2014; Xenellis et al., 2007).
There is an urgent need to uncover the genetic background of
patients with bilateral SSNHL in order to develop more effi-
cient prophylactic and therapeutic strategies.
Here, we report a case of bilateral SSNHL with rapid
profound hearing loss following a common cold, aiming at
exploring the status of immune-related genes. All 232 candi-
date genes involved in immune activity, selected according to
Human Phenotype Ontology (http://human-phenotype-
ontology.github.io/), were sequenced using next generation
sequencing, a high-throughput method to foster novel dis-
covery in biomedical research. The significance of the results
is discussed with reference to recent publications.
2. Case presentation2.1. Clinical dataA 45-year-old man presented with a 7-year history of
bilateral SSNHL. During a night in early January 2008, he
slept in a cold room without covering and experienced a fever
the next morning with a mild occipital headache at noon that
became severe at 4 pm. He took an unknown medicine for
fever in the evening. On the third night, he took a traditional
Chinese medicine for common cold (name unknown) for
continuing fever and headache and slept until noon. Upon
waking up, he became deaf in both ears, accompanied by
unsteadiness. There was no tinnitus, ear fullness, nausea, or
vomiting. He did not receive formal treatment. He was seen by
authors on June 18, 2015 for treatment of his deafness. Neither
air nor bone conduction pure tone audiometry detected any
response at 0.25e8 kHz at the maximum output (Fig. 1). He
was admitted on November 4, 2015 for cochlear implantation.
The patient suffered from hepatitis B in 1988.
Pre-operative routine blood tests showed increased levels of
hematocrit (52.8%), lymphocytes (43.4%) and hemoglobin
(170 g/L), and decreased neutrophils (45.4%). Routine urine
and stool tests were normal. Coagulation test was normal.
Blood biochemical tests demonstrated increased levels of
blood urea nitrogen (7.2 mmol/L), total cholesterol
(5.88 mmol/L), high density lipoprotein (1.92 mmol/L), low
density lipoprotein (3.76 mmol/L) and apolipoprotein A1
(2.12 g/L). Hepatitis B tests were positive for anti-core antigen
antibody, and negative for surface antigen, E-antigen, anti-
surface antigen IgG antibodies or anti-E-antigen IgM anti-
body. Antibodies against hepatitis C virus, human immuno-
deficiency virus or syphilis were negative. Auditory brainstem
responses could not be induced in either ear to click stimu-
lation at 80 dB nHL. Neither ocular vestibular-evoked
myogenic potentials (oVEMPs) nor cervical vestibular-evoked myogenic potentials (cVEMPs) were elicited to
500 Hz tone burst stimulation at 97 dB nHL. CT images
showed normal inner ear and vestibular aqueduct but round
window membranous ossification on both sides (Fig. 2).
Heavy T2-weighted MRI showed normal fluid patterns in the
inner ear on both sides (Fig. 3). He received a cochlear implant
(CS-10A, Zhejiang Nurotron Biotechnology Co., Ltd., Hang-
zhou, China) in right ear on November 9, 2015. Right side
round wind membrane ossification was substantiated during
surgery. The patient was not satisfied with the hearing out-
comes at 4 months post-implantation, citing narrow dynamic
range and broadness of the response, as well as monotonal
sounds, which made understanding speech difficult, especially
in noise. EDTA treated blood was taken on November 10,
2015 for gene sequencing. Pursuit tracking, optokinetic
nystagmus, sera immunoglobulin levels, C-reactive protein,
and complements C3 and C4 tests were completed on March
15, 2016.2.2. Gene sequencingA total of 232 immune-associated genes were sequenced
using an Illumina HiSeq 2000 Sequencer (Illumina, California,
USA) (Supporting material-Table 1). After DNA extraction
from peripheral white blood cells, the sequenced sample was
prepared according to the Illumina protocol. Briefly, 3 mg of
genomic DNA was fragmented by nebulization (Covaris S2
system, Thermo Fisher Scientific Inc., Waltham, USA), and
the fragmented DNAwas repaired. An ‘A’ was ligated to the 30
end, Illumina adapters were then ligated to the fragments. The
sample was size selected for a 350e400 base pair product,
which was PCR amplified (for primer information see
Supporting material-Table 2A), and the final product was
validated using the Agilent Bioanalyzer. The amplified DNA
was captured with a target region related gene enrichment
system (MyGenostics, MD, USA) based on previously
described technologies (Huang et al., 2013). The capture
experiment was conducted according to the manufacturer's
protocol. In brief, a 1 mg DNA library was mixed with buffer
BL and the GenCap target region probe (MyGenostics, MD,
USA) and then heated at 95 C for 7 min and 65 C for 2 min
on a PCR machine. Next, 23 ml of the 65 C pre-warmed
buffer HY (MyGenostics, MD, USA) was added to the
mixture, which was held at 65 C with PCR lid heat on for
22 h for hybridization. Fifty microliters of MyOne beads (Life
Technology) were washed in 500 ml 1 binding buffer 3 times
and resuspended in 80 ml 1 binding buffer. We added 64 ml
2 binding buffer to the hybrid mixture and transferred this to
a tube with 80 ml MyOne beads. The mixture was rotated for
1 h on a rotator. The beads were then washed with WB1 buffer
at room temperature for 15 min once and with WB3 buffer at
65 C for 15 min three times. The bound DNAwas then eluted
with elution buffer. The eluted DNA was finally amplified for
15 cycles using the following program (for primer information
see Supporting material-Table 2B): 98 C for 30 s (1 cycle),
98 C for 25 s, 65 C for 30 s, 72 C for 30 s (15 cycles) and
then 72 C for 5 min (1 cycle). The PCR product was purified
Fig. 1. Audiogram of a patient with bilateral sudden sensorineural hearing loss. Profound sensorineural hearing loss was detected in both ears.
Fig. 2. CT image of the inner ear in a patient with bilateral sudden sensori-
neural hearing loss. The middle ear (A) and inner ear including the vestibular
aqueduct (VA) are (B) normally developed. The bright signal in area of round
window membrane (black frame) indicates round window membrane ossifi-
cation (RWO) in both ears (C). AC: anterior crus of the stapes; LC: long crus
of the incus; MM: manubrium of malleus; OW: oval window. Scale
bars ¼ 10 mm in A and B, and 5 mm in C and D.
Fig. 3. Heavy T2-weighted MRI of the inner ear in a patient with bilateral
sensorineural hearing loss. All compartments of the inner ear on both sides are
filled with fluids. Am: ampulla; Coch: cochlea; Vest: vestibule. Scale
bars ¼ 5 mm.
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according to the manufacturer's protocol. The enrichment li-
braries were sequenced on an Illumina HiSeq 2000 sequencer
for 100 bp paired reads. The data were analyzed as follows.Reference genome: The reads were mapped against UCSC
hg19 (http://genome.ucsc.edu/). Read mapping: The reads
were mapped by SOAPaligner (http://soap.genomics.org.cn/
soapaligner.html) and Burrows-Wheeler Aligner (BWA)
(http://bio-bwa.sourceforge.net/bwa.shtml). Variant detection:
The SNPs and indels were detected by GATK and SOAPsnp
(http://soap.genomics.org.cn/soapsnp.html). Variant database:
dbSNP & 1000G. The mutated genes were validated using first
generation sequencing with an ABI PRISM 310 Genetic
Analyzer (Thermo Fisher Scientific Inc., Waltham, USA) (for
primer information see Supporting material-Table 2C).
As a result, mutations were detected in 5 genes, including
phosphoinositide 3-kinase catalytic subunit delta (PIK3CD),
caspase recruitment domain-containing protein 9 (CARD9),
complement factor H-related (CFHR2), immunoglobulin
81J. Zou et al. / Journal of Otology 11 (2016) 78e83lambda-like polypeptide 1 protein (IGLL1), and trans-
membrane channel-like gene family 8 (TMC8) (Table 1). For
the PIK3CD gene, a c.C896T substitute in exon 7 was
detected. This mutation causes primary immunodeficiency,
which is an autosomal dominant disease (Angulo et al., 2013;
Lucas et al., 2014). A heterozygous c.A586G substitution in
exon 4 of the caspase recruitment domain-containing protein 9
(CARD9) gene was found. Deficiency of the gene is a recently
described autosomal-recessive primary immunodeficiency
marked by susceptibility to candidiasis (Gavino et al., 2014).
A deletion of c.655e656 in exon 5 of the complement factor H
related protein 2 (CFHR2) gene was found, which may be
involved in autosomal-recessive neovascular diseases (Kubista
et al., 2011; Sethi et al., 2011; Zhang et al., 2008). A c.T485A
substitute in exon 3 of the immunoglobulin lambda-like
polypeptide 1 (IGLL1) gene was found. Mutations in this
gene can result in an autosomal recessive disease of B cell
deficiency and agammaglobulinemia (Khalili et al., 2014). A
c.G1967A substitute in exon 16 of the transmembrane
channel-like protein 8 (TMC8) gene was also revealed in the
patient. Homozygous, invalidating mutations in either the
TMC8 or TMC6 gene are found in approximately 75% of
epidermodysplasia verruciformis patients and confer suscep-
tibility to the disease (Orth, 2006; Ramoz et al., 1999, 2002).
Most patients demonstrate autosomal recessive patterns of
inheritance, although some exhibit X-linked recessive or
autosomal dominant inheritance (Yoshida et al., 2014).
Pursuit tracking and optokinetic nystagmus tests showed
normal results, which did not support a central nerve system
lesion. Complement C3 was below the normal value, and
complement C4 and IgG were in the lower range of normal
values.
3. Discussion
In the present report, we presented results of genetic studies
using next generation sequencing in a patient with bilateral
SSNHL that revealed a novel mutation in the phosphoinositide
3-kinase catalytic subunit delta (PIK3CD) gene leading to
primary immunodeficiency (Angulo et al., 2013; Lucas et al.,Table 1
Mutations detected in the immune-related genes using next generation sequencing
Genes MuLoc NoTra Exons NuCh
PIK3CD chr1-
9777132
005026 exon7 c.C896T
CARD9 chr9-
139265334
052813 exon4 c.A586G
CFHR2 chr1-
196928052
196928053
005666 exon5 c.655-656del
IGLL1 chr22-
23915610
020070 exon3 c.T485A
TMC8 chr17-
76136979
152468 exon16 c.G1967A
Supporting references as following: # Angulo et al., 2013; Lucas et al., 2014. & Ga
Khalili et al., 2014. £ Yoshida et al., 2014. AD: autosome dominant; AR: autosome
DCFHR: deficiency in complement factor H-related protein; del: deletion; EDV:
dividuals; Het: heterozygote; Hom: homozygote; IFD: invasive fungal disease; Inh2014) together with mutations in another 4 genes associated
with autosomal-recessive primary immunodeficiency.
Although the other mutations were heterozygous in immune-
related genes with autosomal recessive inheritance, a carrier
with a heterozygous mutation of an autosomal recessive gene
has an increased health risk. Ataxia-telangiectasia is an auto-
somal recessive neurodegenerative disorder with immunode-
ficiency and an increased risk of developing cancer caused by
mutations in the ataxia-telangiectasia mutated gene. Female
carriers of the ataxia-telangiectasia mutation have an increased
risk of breast cancer (van Os et al., 2015). In the present case,
there might be a combined effect from mutations of the
CARD9, CFHR2, IGLL1, and TMC8 genes as they are all
associated with autosomal recessive diseases. Low levels of
complements C3, C4 and IgG in the patient support the
phenotype of immunodeficiency.
The present case of bilateral SSNHL with primary immu-
nodeficiency is different from previous reports of an associa-
tion with an autoimmune reaction (Sara et al., 2014). It is
possible that the immunodeficiency status of the patient
reduced the defending activity against the virus propagation
that caused severe impairment in the inner ear. In addition to
the low level of complement C3, the patient has a deletion of
655e656 in exon 5 of the complement factor H related protein
2 (CFHR2) gene. It was reported that complement factor H
(CFH) polymorphism was significantly related to SSNHL
(Nishio et al., 2012). CFH is a glycoprotein that plays a critical
role in the regulation of the complement system through the
assembly and decay of the alternative pathway C3 pro-
convertase and C3 convertase (Bettoni et al., 2016). The level
of serum CFH correlates with the efficacy of opsonophago-
cytic killing of pneumococci (van der Maten et al., 2016).
Viral and bacterial infections were reportedly involved in
SSNHL (Cassilde et al., 2014; Dunne et al., 2004; Garcia
Berrocal et al., 2000; Pyykko and Zou, 2008). The increased
level of total cholesterol in the present case may also influence
hearing prognosis (Quaranta et al., 2015). The poor outcome
of cochlear implantation in the patient might result from se-
vere degeneration of spiral ganglion cells during the infection
(Seyyedi et al., 2014). An eABR test that estimates theand the resulting phenotypes.
AACh Hom/Het FreNor Inh Disease/phenotype
P299L Het 0.0002 AD# PID 14
K196E Het e AR& IFD
I219fs Het 0.0020 AR¤ DCFHR
M162K Het 0.0383 AR¥ CAG
S656N Het e AR£ EDV
vino et al., 2014. ¤ Kubista et al., 2011; Sethi et al., 2011; Zhang et al., 2008. ¥
recessive; BuLoc: nucleotide changes; CAG: congenital agammaglobulinemia;
epidermodysplasia verruciformis; FreNor: mutation frequency in normal in-
: inheritance; NoTra: number of transcripts; PID: primary immunodeficiency.
82 J. Zou et al. / Journal of Otology 11 (2016) 78e83responses of spiral ganglion cells should have been included in
pre-cochlear implantation evaluation and can help predict CI
outcomes, which however is not done as a routine test in the
clinic yet.
The patient did not provide a history of being susceptible to
other infections. It is recently reported that PI3KD is a key
regulator of CD8þ T cell responses that integrates extrinsic
cues, including those from other responding cells, to deter-
mine the collective behavior of CD8þ T cell populations
responding to infection. The authors observed that inactivation
of PI3KD resulted in enhanced bacterial elimination by the
innate immune system. However, the magnitudes of the pri-
mary and secondary CD8þ T cell responses were reduced.
Moreover, PI3KD activity was required for CD8þ T cells to
provide help to other responding CD8þ cells (Pearce et al.,
2015). We suspect that the immune system of the patient has
sufficient reaction to combat mild infection.
In conclusion, the current case demonstrates that a PIK3CD
C896T mutation responsible for primary immunodeficiency
may contribute to the onset of bilateral SSNHL with a rapid
progression.Appendix A. Supplementary data
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.joto.2016.06.001.
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